Study identifier:NIS-CKR-DUM-2008/2
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
A retrospective, multi centre, non-interventional, observational study to investigate treatment pattern of blood pressure in the type II diabetes mellitus patients with hypertension.
hypertension
-
No
-
All
2000
Observational
18 Years +
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Jan 2015 by AstraZeneca Pharmaceuticals
AstraZeneca Pharmaceuticals
-
This study will address the treatment rate and control rate of hypertension, treatment pattern and factors to affect blood pressure control by examining (retrospective) medical records of hypertension patients having Type 2 Diabetes mellitus, among outpatients coming to the Endocrinology Department in 20 general hospital settings nationwide.
Location
Location
Bucheon, Gyeonggi, Republic of Korea
Location
Busan, Republic of Korea
Location
Deagu, Republic of Korea
Location
Deajeon, Republic of Korea
Location
Goyang, Gyeonggi, Republic of Korea
Location
Guri, Gyeonggi, Republic of Korea
Location
Incheon, Republic of Korea
Location
Jeonju, Keollabuk, Republic of Korea
Arms | Assigned Interventions |
---|---|
1 Hypertension patients with Type II Diabetes mellitus | - |
This information is not intended to replace the informed medical advice or medical treatments of a healthcare professional. Only a physician can determine if a specific medicine is the correct treatment for a particular patient. If you have questions regarding any information contained in this site, you must consult a suitably qualified healthcare professional. Before prescribing any AstraZeneca products, Healthcare Professionals should view their country specific information.